Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline

J Card Fail. 2009 Mar;15(2):83-97. doi: 10.1016/j.cardfail.2009.01.006.


Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.

Publication types

  • Practice Guideline

MeSH terms

  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / genetics*
  • Cardiomyopathies / physiopathology
  • Genetic Counseling
  • Genetic Testing
  • Humans
  • Risk Assessment
  • Societies, Medical
  • United States